| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $46K | — | — |
| SG&A Expense | $1.5M | +44.0% | -48.6% |
| Operating Income | -$1.6M | -53.3% | +45.2% |
| Income Tax | $912 | +0.0% | — |
| Net Income | -$2.2M | -130.9% | +26.8% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $586K | +33.4% | — |
| Total Assets | $1.9M | +25.1% | — |
| Current Liabilities | $10.7M | +22.0% | — |
| Total Liabilities | $11.5M | +24.1% | — |
| Stockholders' Equity | -$9.6M | -24.0% | -1084.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.6M | — | — |
| Capital Expenditures | $858K | — | — |
| Investing Cash Flow | -$858K | — | — |
| Financing Cash Flow | $2.7M | — | — |
| Free Cash Flow | -$2.5M | — | — |